Abbott Laboratories (ABT) — Financial statements
Income statement, balance sheet, and cash flow for Abbott Laboratories — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 44,328↑5.7% | 41,950↑4.6% | 40,109↓8.1% | 43,653↑1.3% | 43,075 | |
| Cost of Revenue | 19,721↓4.4% | 20,625↑2.8% | 20,072↓5.9% | 21,330↑7.4% | 19,861 | |
| Gross Profit | 24,607↑15.4% | 21,325↑6.4% | 20,037↓10.2% | 22,323↓3.8% | 23,214 | |
| Operating Expenses | ||||||
| R&D Expenses | 2,955↑4.7% | 2,823↑3.8% | 2,719↓4.7% | 2,852↑4.2% | 2,738 | |
| General & Administrative Expenses | 12,378 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 12,378↑6.2% | 11,651↑7.1% | 10,883↓2.0% | 11,109↓1.5% | 11,276 | |
| Other Expenses | 1,253 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 16,586↑14.6% | 14,474↑6.4% | 13,602↓2.6% | 13,961↓0.4% | 14,014 | |
| Total Costs & Expenses | 36,280↑3.4% | 35,099↑4.2% | 33,674↓4.6% | 35,291↑4.2% | 33,875 | |
| Operating Results | ||||||
| Operating Income | 8,048↑17.9% | 6,825↑6.1% | 6,435↓23.0% | 8,362↓9.1% | 9,200 | |
| Depreciation & Amortization | 2,746↓14.7% | 3,218↓0.8% | 3,243↓0.7% | 3,267↓7.7% | 3,538 | |
| EBITDA | 11,553↑6.6% | 10,834↑2.2% | 10,605↓10.8% | 11,888↓2.2% | 12,159 | |
| EBIT | 8,807↑15.6% | 7,616↑3.5% | 7,362↓14.6% | 8,621↑0.0% | 8,621 | |
| Interest & Other Income | ||||||
| Net Interest Income | -111↑57.1% | -259↑17.3% | -313↓137.1% | -132↑64.0% | -367 | |
| Interest Income | 230↓33.1% | 344↓10.6% | 385↑110.4% | 183↑325.6% | 43 | |
| Interest Expense | 341↓43.4% | 603↓13.6% | 698↑121.6% | 315↓23.2% | 410 | |
| Non-Operating Income | -759↑0.8% | -765↑17.5% | -927↓257.9% | -259↓144.7% | 579 | |
| Other Income / Expenses | 418↑122.3% | 188↓17.9% | 229↑508.9% | -56↑94.3% | -989 | |
| Income Before Tax | 8,466↑20.7% | 7,013↑5.2% | 6,664↓19.8% | 8,306↑1.2% | 8,211 | |
| Income Tax Expense | 1,942↑130.4% | -6,389↓779.0% | 941↓31.5% | 1,373↑20.4% | 1,140 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 6,524↓51.3% | 13,402↑134.2% | 5,723↓17.5% | 6,933↓2.0% | 7,071 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 6,524↓51.3% | 13,402↑134.2% | 5,723↓17.5% | 6,933↓2.0% | 7,071 | |
| Bottom-Line Net Income | 6,524↓51.3% | 13,402↑134.2% | 5,723↓17.5% | 6,933↓2.0% | 7,071 | |
| EPS (Basic) | 3.74↓51.2% | 7.67↑132.4% | 3.30↓16.2% | 3.94↓0.8% | 3.97 | |
| EPS (Diluted) | 3.72↓51.3% | 7.64↑133.6% | 3.27↓16.4% | 3.91↓0.8% | 3.94 | |
| Weighted Average Shares | 1,747↑0.9% | 1,732↓0.1% | 1,734↓1.1% | 1,753↓1.2% | 1,775 | |
| Weighted Average Diluted Shares | 1,747↓0.1% | 1,748↓0.1% | 1,749↓0.9% | 1,764↓1.4% | 1,789 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.